The FDA Grants Rare Pediatric Disease Designation to Odiparcil for the Treatment of MPS VI 03.18-2019 Medications Comments Off on The FDA Grants Rare Pediatric Disease Designation to Odiparcil for the Treatment of MPS VI
FDA Approves Dupixent (dupilumab) for Moderate-to-Severe Atopic Dermatitis in Adolescents 03.13-2019 Medications Comments Off on FDA Approves Dupixent (dupilumab) for Moderate-to-Severe Atopic Dermatitis in Adolescents
FDA Approves Trazimera (trastuzumab-qyyp), a Biosimilar to Herceptin 03.12-2019 Medications Comments Off on FDA Approves Trazimera (trastuzumab-qyyp), a Biosimilar to Herceptin
FDA Chief Dr. Scott Gottlieb Resigns 03.06-2019 Health News Comments Off on FDA Chief Dr. Scott Gottlieb Resigns
FDA warns of raw cookie dough dangers 12.12-2018 Health News Comments Off on FDA warns of raw cookie dough dangers
New Flu Treatment Approved For Coming Flu Season 10.25-2018 Health News Comments Off on New Flu Treatment Approved For Coming Flu Season
FDA approves new single-dose drug to treat flu 10.25-2018 Health News Comments Off on FDA approves new single-dose drug to treat flu
